HemoGenix

HemoGenix® is a CRO and development company specializing in testing compounds for their effects on stem cells of the blood-forming system. As the leader in stem cell hemotoxicity testing, Hemogenix® focuses on non-invasive, physiological and cell-based screening and monitoring assays to help detect, qualify and predict the effect of agents being developed by biotech and pharmaceutical companies.

Activity:

- Contract Research
- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Hematology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Australia/New-Zealand

c. Countries active: United States, Germany, Great Britain, France, Italy, Canada, Australia, Ireland

Corporate data:

Number of Employees: 5

Turnover:

Amount:	Year:	Currency:
500k	2002	US Dollar

Year founded: 2000